Contexium

NP47926 Biologic, Biosimilar’s and Methotrexate Injections

NP47926 Biologic, Biosimilar’s and Methotrexate Injections is a published development and funding opportunity on Contexium. The donor or funder is The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland). Project location(s): United Kingdom. Applications close on 21 Oct 2026. Budget: 334,866,015 GBP. Supply of Biologics, Biosimilars and Methotrexate Injections to NHS Scotland.

Opportunity overview

Project name
NP47926 Biologic, Biosimilar’s and Methotrexate Injections
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) logo
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
Donor
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)

Key details

Opportunity start date
Opportunity end date
Proposed project start date
Project location(s)
United Kingdom
Budget
334,866,015
Currency
UK Pound Sterling

Summary

Supply of Biologics, Biosimilars and Methotrexate Injections to NHS Scotland.

Frequently asked questions

What is NP47926 Biologic, Biosimilar’s and Methotrexate Injections?

NP47926 Biologic, Biosimilar’s and Methotrexate Injections is a published development and funding opportunity on Contexium. The donor or funder is The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland). Project location(s): United Kingdom. Applications close on 21 Oct 2026. Budget: 334,866,015 GBP. Supply of Biologics, Biosimilars and Methotrexate Injections to NHS Scotland.

Who is funding NP47926 Biologic, Biosimilar’s and Methotrexate Injections?

NP47926 Biologic, Biosimilar’s and Methotrexate Injections is funded by The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland).

When is the deadline to apply for NP47926 Biologic, Biosimilar’s and Methotrexate Injections?

The application deadline is 21 Oct 2026 12:00 (UTC).

Where will the NP47926 Biologic, Biosimilar’s and Methotrexate Injections project take place?

The project location(s) are: United Kingdom.

What is the budget for NP47926 Biologic, Biosimilar’s and Methotrexate Injections?

The available budget is 334,866,015 GBP.

How can I apply for NP47926 Biologic, Biosimilar’s and Methotrexate Injections?

Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.